Universal Health, US9139031002

Universal Health shifts Q3 results to October 27. Leerink targets Universal Health stock at USD 205

Published on 10/15/2026 at 12:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The call is now set for October 28 at 8:00 a.m. ET. Universal Health stock costs EUR 167.00 on October 15, 2026.

Results date and operating figures

  • Universal Health changed its third-quarter reporting schedule on October 9, 2026.
  • Second-quarter revenue reached USD 4.64 billion and diluted earnings per share were USD 5.98.
  • Universal Health stock trades at EUR 167.00 at 12:49 p.m. CEST at Lang & Schwarz on October 15, 2026.
Universal Health, US9139031002, Illustration mit AI erstellt.

Universal Health Services stock is priced at EUR 167.00 at Lang & Schwarz on October 15, 2026, while the company has moved its third-quarter results to October 27. GlobeNewswire reported on October 9, 2026, that the company will publish results for the quarter ended September 30 after the market closes on October 27, with the conference call set for October 28 at 8:00 a.m. ET. Separately, Leerink Partners raised its price target from USD 198 to USD 205 and maintained an Outperform rating on September 18, 2026, according to MarketScreener.

Second-quarter figures set the base

Universal Health entered the reporting date with second-quarter revenue of USD 4.64 billion, net income attributable to common shareholders of USD 358.45 million and diluted earnings per share of USD 5.98 for the quarter ended June 30, 2026. Operating margin was 11.00 percent in that period. The figures provide a concrete benchmark for the coming release because the third quarter ended September 30.

MarketBeat lists a consensus estimate of USD 5.20 for third-quarter earnings per share and USD 4.71 billion for revenue. Against the year-earlier comparison of USD 5.69 earnings per share and USD 4.50 billion revenue, the estimates imply lower earnings but higher revenue.

What happens on the reporting dates

The chronology shows the sequence clearly: on July 28, 2026, Universal Health reported second-quarter diluted earnings per share of USD 5.98; on September 18, 2026, Leerink Partners raised its target to USD 205; and on October 9, 2026, the company set the revised third-quarter release date for October 27.

Dates now set for investors

The next two scheduled events are the third-quarter results after the market close on October 27, 2026, followed by the conference call at 8:00 a.m. ET on October 28, 2026. The revised schedule gives the upcoming report a precise timing anchor.

Stock trades at Lang and Schwarz

Universal Health Services stock was trading at EUR 167.00 at Lang & Schwarz on October 15, 2026, at 12:49 p.m. CEST. The primary listing is on the NYSE, where the latest structured quote was USD 185.89 on October 14, 2026, before the US market opened on October 15.

The further course of trading is shown by the continuously updated real-time quote of Universal Health stock.

Universal Health Services stock facts

  • Company: Universal Health Services, Inc.
  • ISIN: US9139031002
  • Ticker: UHS
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 12:49 p.m. CEST): EUR 167.00
  • Sector / Industry: Healthcare / Medical Care Facilities
  • Index membership: S&P 500

Market context: Market report S&P 500.

More news and analyses on Universal Health stock

Disclaimer...
en | US9139031002 | UNIVERSAL HEALTH | boerse | 70329170 |